G-CSF prevents progression of diabetic nephropathy in rat.

BACKGROUND: The protective effects of granulocyte colony-stimulating factor (G-CSF) have been demonstrated in a variety of renal disease models. However, the influence of G-CSF on diabetic nephropathy (DN) remains to be examined. In this study, we investigated the effect of G-CSF on DN and its possi...

Full description

Bibliographic Details
Main Authors: Byung-Im So, Yi-Sun Song, Cheng-Hu Fang, Jun-Young Park, Yonggu Lee, Jeong Hun Shin, Hyuck Kim, Kyung-Soo Kim
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3805566?pdf=render
_version_ 1818561309932781568
author Byung-Im So
Yi-Sun Song
Cheng-Hu Fang
Jun-Young Park
Yonggu Lee
Jeong Hun Shin
Hyuck Kim
Kyung-Soo Kim
author_facet Byung-Im So
Yi-Sun Song
Cheng-Hu Fang
Jun-Young Park
Yonggu Lee
Jeong Hun Shin
Hyuck Kim
Kyung-Soo Kim
author_sort Byung-Im So
collection DOAJ
description BACKGROUND: The protective effects of granulocyte colony-stimulating factor (G-CSF) have been demonstrated in a variety of renal disease models. However, the influence of G-CSF on diabetic nephropathy (DN) remains to be examined. In this study, we investigated the effect of G-CSF on DN and its possible mechanisms in a rat model. METHODS: Otsuka Long-Evans Tokushima Fatty (OLETF) rats with early DN were administered G-CSF or saline intraperitoneally. Urine albumin creatinine ratio (UACR), creatinine clearance, mesangial matrix expansion, glomerular basement membrane (GBM) thickness, and podocyte foot process width (FPW) were measured. The levels of interleukin (IL)-1β, transforming growth factor (TGF)-β1, and type IV collagen genes expression in kidney tissue were also evaluated. To elucidate the mechanisms underlying G-CSF effects, we also assessed the expression of G-CSF receptor (G-CSFR) in glomeruli as well as mobilization of bone marrow (BM) cells to glomeruli using sex-mismatched BM transplantation. RESULTS: After four weeks of treatment, UACR was lower in the G-CSF treatment group than in the saline group (p<0.05), as were mesangial matrix expansion, GBM thickness, and FPW (p<0.05). In addition, the expression of TGF-β1 and type IV collagen and IL-1β levels was lower in the G-CSF treatment group (p<0.05). G-CSFR was not present in glomerular cells, and G-CSF treatment increased the number of BM-derived cells in glomeruli (p<0.05). CONCLUSIONS: G-CSF can prevent the progression of DN in OLETF rats and its effects may be due to mobilization of BM cells rather than being a direct effect.
first_indexed 2024-12-14T00:49:11Z
format Article
id doaj.art-cb4bec2683874e43b37639c7cb64a30e
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-14T00:49:11Z
publishDate 2013-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-cb4bec2683874e43b37639c7cb64a30e2022-12-21T23:23:57ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-01810e7704810.1371/journal.pone.0077048G-CSF prevents progression of diabetic nephropathy in rat.Byung-Im SoYi-Sun SongCheng-Hu FangJun-Young ParkYonggu LeeJeong Hun ShinHyuck KimKyung-Soo KimBACKGROUND: The protective effects of granulocyte colony-stimulating factor (G-CSF) have been demonstrated in a variety of renal disease models. However, the influence of G-CSF on diabetic nephropathy (DN) remains to be examined. In this study, we investigated the effect of G-CSF on DN and its possible mechanisms in a rat model. METHODS: Otsuka Long-Evans Tokushima Fatty (OLETF) rats with early DN were administered G-CSF or saline intraperitoneally. Urine albumin creatinine ratio (UACR), creatinine clearance, mesangial matrix expansion, glomerular basement membrane (GBM) thickness, and podocyte foot process width (FPW) were measured. The levels of interleukin (IL)-1β, transforming growth factor (TGF)-β1, and type IV collagen genes expression in kidney tissue were also evaluated. To elucidate the mechanisms underlying G-CSF effects, we also assessed the expression of G-CSF receptor (G-CSFR) in glomeruli as well as mobilization of bone marrow (BM) cells to glomeruli using sex-mismatched BM transplantation. RESULTS: After four weeks of treatment, UACR was lower in the G-CSF treatment group than in the saline group (p<0.05), as were mesangial matrix expansion, GBM thickness, and FPW (p<0.05). In addition, the expression of TGF-β1 and type IV collagen and IL-1β levels was lower in the G-CSF treatment group (p<0.05). G-CSFR was not present in glomerular cells, and G-CSF treatment increased the number of BM-derived cells in glomeruli (p<0.05). CONCLUSIONS: G-CSF can prevent the progression of DN in OLETF rats and its effects may be due to mobilization of BM cells rather than being a direct effect.http://europepmc.org/articles/PMC3805566?pdf=render
spellingShingle Byung-Im So
Yi-Sun Song
Cheng-Hu Fang
Jun-Young Park
Yonggu Lee
Jeong Hun Shin
Hyuck Kim
Kyung-Soo Kim
G-CSF prevents progression of diabetic nephropathy in rat.
PLoS ONE
title G-CSF prevents progression of diabetic nephropathy in rat.
title_full G-CSF prevents progression of diabetic nephropathy in rat.
title_fullStr G-CSF prevents progression of diabetic nephropathy in rat.
title_full_unstemmed G-CSF prevents progression of diabetic nephropathy in rat.
title_short G-CSF prevents progression of diabetic nephropathy in rat.
title_sort g csf prevents progression of diabetic nephropathy in rat
url http://europepmc.org/articles/PMC3805566?pdf=render
work_keys_str_mv AT byungimso gcsfpreventsprogressionofdiabeticnephropathyinrat
AT yisunsong gcsfpreventsprogressionofdiabeticnephropathyinrat
AT chenghufang gcsfpreventsprogressionofdiabeticnephropathyinrat
AT junyoungpark gcsfpreventsprogressionofdiabeticnephropathyinrat
AT yonggulee gcsfpreventsprogressionofdiabeticnephropathyinrat
AT jeonghunshin gcsfpreventsprogressionofdiabeticnephropathyinrat
AT hyuckkim gcsfpreventsprogressionofdiabeticnephropathyinrat
AT kyungsookim gcsfpreventsprogressionofdiabeticnephropathyinrat